Surface Oncology, Inc.
SURF · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $45,724 | $211,483 | $352,430 | $52,367 |
| - Cash | $50,910 | $56,045 | $175,141 | $46,755 |
| + Debt | $56,037 | $57,308 | $49,269 | $25,039 |
| Enterprise Value | $50,851 | $212,746 | $226,558 | $30,651 |
| Revenue | $30,000 | $2,687 | $126,162 | $15,360 |
| % Growth | 1,016.5% | -97.9% | 721.4% | – |
| Gross Profit | $30,000 | $2,687 | $126,162 | $15,360 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$61,869 | -$76,013 | $61,586 | -$57,366 |
| % Margin | -206.2% | -2,828.9% | 48.8% | -373.5% |
| Net Income | -$65,303 | -$79,462 | $59,337 | -$53,004 |
| % Margin | -217.7% | -2,957.3% | 47% | -345.1% |
| EPS Diluted | -1.17 | -1.8 | 1.57 | -1.9 |
| % Growth | 35% | -214.6% | 182.6% | – |
| Operating Cash Flow | -$59,552 | -$62,344 | $29,997 | -$60,140 |
| Capital Expenditures | -$497 | -$120 | -$43 | -$1,538 |
| Free Cash Flow | -$60,049 | -$62,464 | $29,954 | -$61,678 |